Manuscripts
Showing 1543 manuscripts.
Beta-interferon therapy in patients with poor-prognosis Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). A phase II trial with preliminary evidence of antiviral activity and low incidence of opportunistic infections
Citation
Steven A. Miles, HeJing Wang, Eduardo Cortes, Judith Carden, S. Marcus, Ronald T. Mitsuyasu. Beta-interferon therapy in patients with poor-prognosis Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). A phase II trial with preliminary evidence of antiviral activity and low incidence of opportunistic infections. Annals of Internal Medicine. 1990. 112: 582-9.Year
1990
Journal
Annals of Internal Medicine
The use of myeloid hematopoietic growth factors in patients with HIV infection
Citation
Ronald T. Mitsuyasu, Steven A. Miles, David W. Golde. The use of myeloid hematopoietic growth factors in patients with HIV infection. International Journal of Cell Cloning. 1990. 8: 347-55.Year
1990
Journal
International Journal of Cell Cloning
Multiple-dose pharmacokinetics of oral zidovudine in hemophilia patients with human immunodeficiency virus infection
Citation
Gene D. Morse, Amy Portmore, Jeffery Olson, Charlene Taylor, Carol S. Plank, Richard C. Reichman. Multiple-dose pharmacokinetics of oral zidovudine in hemophilia patients with human immunodeficiency virus infection. Antimicrobial Agents and Chemotherapy. 1990. 34: 394-7.Year
1990
Journal
Antimicrobial Agents and Chemotherapy
The Epstein-Barr virus BRLF1 immediate-early gene product transactivates the human immunodeficiency virus type 1 long terminal repeat by a mechanism which is enhancer independent
Citation
Evelyn Byrd Quinlivan, Elizabeth A. Holley-Guthrie, Eng-Chung Mar, Marilyn S. Smith, Shannon Kenney. The Epstein-Barr virus BRLF1 immediate-early gene product transactivates the human immunodeficiency virus type 1 long terminal repeat by a mechanism which is enhancer independent. Journal of Virology. 1990. 64: 1817-20.Year
1990
Journal
Journal of Virology
Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus
Citation
Douglas D. Richman, Janet Grimes, Stephen W. Lagakos. Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus. Journal of Acquired Immune Deficiency Syndromes. 1990. 3: 743-6.Year
1990
Journal
Journal of Acquired Immune Deficiency Syndromes
Titration of human immunodeficiency virus type 1 (HIV-1) and quantitative analysis of virus expression in vitro using liquid RNA-RNA hybridization
Citation
David Volsky, Michael G. Pellegrino, Gongrong Li, K. A. Logan, J. E. Aswell, N. P. Lawrence, S. R. Decker. Titration of human immunodeficiency virus type 1 (HIV-1) and quantitative analysis of virus expression in vitro using liquid RNA-RNA hybridization. Journal of Virological Methods. 1990. 28: 257-72.Year
1990
Journal
Journal of Virological Methods
Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures
Citation
P. Peterson, G. Gekker, Kim Sannerud, Henry H. Balfour. Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures. AIDS. 1990. 4: 869-73.Year
1990
Journal
AIDS
A semiquantitative microassay for measurement of relative number of blood mononuclear cells infected with human immunodeficiency virus
Citation
Phalguni Gupta, A. Enrico, John A. Armstrong, M. Doerr, Monto Ho, Charles Rinaldo. A semiquantitative microassay for measurement of relative number of blood mononuclear cells infected with human immunodeficiency virus. AIDS Research and Human Retroviruses. 1990. 6: 1193-6.Year
1990
Journal
AIDS Research and Human Retroviruses
Molecular biology of pneumocystis carinii
Citation
Melanie Cushion, Melanie Cushion, S. Hong, Paul Steele, Saundra L. Stringer, Peter D. Walzer, James R. Stringer. Molecular biology of pneumocystis carinii. Annals of the New York Academy of Sciences. 1990. 616: 415-20.Year
1990
Journal
Annals of the New York Academy of Sciences
Clinical trials of combination therapies for HIV infection. Rationale for development of multidrug therapy
Citation
Daniel F. Hoth. Clinical trials of combination therapies for HIV infection. Rationale for development of multidrug therapy. Journal of Acquired Immune Deficiency Syndromes. 1990. 3: S95-6.Year
1990
Journal
Journal of Acquired Immune Deficiency Syndromes